PT-141 - Research Peptide

PT-141 (Bremelanotide) is a synthetic melanocortin peptide analogue studied for its interaction with melanocortin receptors in laboratory models. Researchers investigate PT-141 for its effects on neurological signalling pathways associated with melanocortin receptor activation. New Wave Peptides supplies PT-141 in 10MG vials, independently lab-tested and verified for purity, strictly for scientific use in controlled laboratory environments.

Download Third Party COA: PT-141 COA - Batch 20070/A
This batch (20070/A) is independently tested by Janoshik and confirmed to exceed 99% purity. Each vial is batch-labelled for traceability and consistent research standards.

• Batch Number: 20070/A
• Peptide Name: PT-141 (Bremelanotide)
• Peptide Type: Melanocortin Receptor Agonist
• Research Only: Yes
• Purity: 99.892%
• Form: Lyophilised Solid
• Size: 10MG
• Mixing Water Required: Yes
• Endotoxin Test: View Endotoxin Report
• Heavy Metal Test: View Heavy Metal Report

Usage and Storage:

PT-141 is supplied as a lyophilised powder to maximise stability and shelf life. Store in a cool, dry place. After reconstitution with sterile or bacteriostatic water, refrigerate and use within the recommended timeframe for laboratory research purposes.

Peptide Mixing Notes

Allow both the vial and the mixing solution to reach room temperature before reconstitution. Slowly introduce the solution down the inside of the vial and gently swirl—do not shake—to maintain peptide integrity.

⚠️ Research Use Only – Important Legal Notice

This product is supplied strictly for laboratory research purposes. It is not intended for human or veterinary use and must not be used for:

• Clinical trials involving humans
• Administration to humans or animals
• Supply to another party for human investigational use